Figure 4
Figure 4. Evolution of neutrophil counts during the first year in patients treated with ATG and CSA with and without G-CSF. The bold red line represents the median, and the yellow surface represents the 75% CI of the neutrophil counts in patients treated with G-CSF; the bold blue line represents the median, and the blue surface represents the 75% CI of the neutrophil counts in patients treated without G-CSF; the gray surface represents the overlapping surface of 75% CI of patients treated with and without G-CSF.

Evolution of neutrophil counts during the first year in patients treated with ATG and CSA with and without G-CSF. The bold red line represents the median, and the yellow surface represents the 75% CI of the neutrophil counts in patients treated with G-CSF; the bold blue line represents the median, and the blue surface represents the 75% CI of the neutrophil counts in patients treated without G-CSF; the gray surface represents the overlapping surface of 75% CI of patients treated with and without G-CSF.

Close Modal

or Create an Account

Close Modal
Close Modal